IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PARAMVEER SALUJA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1376773663
CMS profile
1085642
Location
EL PASO, TX

General Payments · PY2018–2024

$4,697.48

  • Reported across 273 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,041.80

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Nephrology TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,025.80 50
Education $16.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $277.55 15
Medtronic, Inc. $178.95 3
Bayer HealthCare Pharmaceuticals Inc. $153.07 9
ABIOMED $64.05 1
Otsuka America Pharmaceutical, Inc. $58.21 3
CALLIDITAS THERAPEUTICS US INC. $55.90 3
Retrophin, Inc. $41.71 6
Boehringer Ingelheim Pharmaceuticals, Inc. $40.20 2
NOVARTIS PHARMACEUTICALS CORPORATION $36.88 2
Xeris Pharmaceuticals, Inc. $36.18 2
Ardelyx, Inc. $30.95 1
Fresenius USA Marketing, Inc. $21.38 1
Relypsa, Inc. $17.21 1
OPKO Pharmaceuticals, LLC $16.00 1
Amgen Inc. $13.56 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $382.05 27
PY2019 $382.97 29
PY2020 $250.98 10
PY2021 $512.38 44
PY2022 $1,345.99 63
PY2023 $781.31 49
PY2024 $1,041.80 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $64.05 08/15/2024 Food and Beverage Undisputed 01/23/2026 1142290659 CMS
Amgen Inc. $13.56 09/26/2024 Food and Beverage Undisputed 01/23/2026 1116082559 CMS
Ardelyx, Inc. $30.95 12/11/2024 Food and Beverage Undisputed 01/23/2026 1146705535 CMS
AstraZeneca Pharmaceuticals LP $42.03 01/03/2024 Food and Beverage Undisputed 01/23/2026 1105540505 CMS
AstraZeneca Pharmaceuticals LP $15.23 01/12/2024 Food and Beverage Undisputed 01/23/2026 1104706289 CMS
AstraZeneca Pharmaceuticals LP $14.07 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105499108 CMS
AstraZeneca Pharmaceuticals LP $18.91 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105685287 CMS
AstraZeneca Pharmaceuticals LP $16.05 03/23/2024 Food and Beverage Undisputed 01/23/2026 1105749595 CMS
AstraZeneca Pharmaceuticals LP $14.73 04/02/2024 Food and Beverage Undisputed 01/23/2026 1105850908 CMS
AstraZeneca Pharmaceuticals LP $19.24 04/23/2024 Food and Beverage Undisputed 01/23/2026 1104507992 CMS
AstraZeneca Pharmaceuticals LP $13.87 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104718743 CMS
AstraZeneca Pharmaceuticals LP $21.16 05/28/2024 Food and Beverage Undisputed 01/23/2026 1104671287 CMS
AstraZeneca Pharmaceuticals LP $14.91 07/03/2024 Food and Beverage Undisputed 01/23/2026 1105569197 CMS
AstraZeneca Pharmaceuticals LP $15.87 07/17/2024 Food and Beverage Undisputed 01/23/2026 1105657742 CMS
AstraZeneca Pharmaceuticals LP $18.54 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105202985 CMS
AstraZeneca Pharmaceuticals LP $16.73 10/30/2024 Food and Beverage Undisputed 01/23/2026 1105412618 CMS
AstraZeneca Pharmaceuticals LP $19.98 11/04/2024 Food and Beverage Undisputed 01/23/2026 1105670169 CMS
AstraZeneca Pharmaceuticals LP $16.23 12/16/2024 Food and Beverage Undisputed 01/23/2026 1105698494 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.47 01/23/2024 Food and Beverage Undisputed 01/23/2026 1086145137 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.17 02/07/2024 Food and Beverage Undisputed 01/23/2026 1086158666 CMS
Bayer Healthcare Pharmaceuticals Inc. $10.47 03/05/2024 Food and Beverage Undisputed 01/23/2026 1086091929 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.48 03/15/2024 Food and Beverage Undisputed 01/23/2026 1086225752 CMS
Bayer Healthcare Pharmaceuticals Inc. $9.93 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086089947 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.91 05/07/2024 Food and Beverage Undisputed 01/23/2026 1086157554 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.13 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086110348 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.40 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086216127 CMS
Bayer Healthcare Pharmaceuticals Inc. $9.11 10/17/2024 Food and Beverage Undisputed 01/23/2026 1086089911 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.20 06/04/2024 Food and Beverage Undisputed 01/23/2026 1117986449 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.00 12/04/2024 Food and Beverage Undisputed 01/23/2026 1117986451 CMS
CALLIDITAS THERAPEUTICS US INC. $22.21 07/25/2024 Food and Beverage Undisputed 01/23/2026 1141519301 CMS
CALLIDITAS THERAPEUTICS US INC. $19.73 10/07/2024 Food and Beverage Undisputed 01/23/2026 1141524178 CMS
CALLIDITAS THERAPEUTICS US INC. $13.96 12/02/2024 Food and Beverage Undisputed 01/23/2026 1141528343 CMS
Fresenius USA Marketing, Inc. $21.38 11/07/2024 Food and Beverage Undisputed 01/23/2026 1154204104 CMS
Medtronic, Inc. $145.99 09/26/2024 Food and Beverage Undisputed 01/23/2026 1119292585 CMS
Medtronic, Inc. $11.95 09/27/2024 Food and Beverage Undisputed 01/23/2026 1119292587 CMS
Medtronic, Inc. $21.01 10/17/2024 Food and Beverage Undisputed 01/23/2026 1119292589 CMS
Novartis Pharmaceuticals Corporation $13.52 09/30/2024 Food and Beverage Undisputed 01/23/2026 1087340235 CMS
Novartis Pharmaceuticals Corporation $23.36 10/23/2024 Food and Beverage Undisputed 01/23/2026 1087340229 CMS
OPKO Pharmaceuticals, LLC $16.00 06/12/2024 Education Undisputed 01/23/2026 1112849444 CMS
Otsuka America Pharmaceutical, Inc. $19.44 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118975042 CMS
Otsuka America Pharmaceutical, Inc. $19.30 05/29/2024 Food and Beverage Undisputed 01/23/2026 1118975044 CMS
Otsuka America Pharmaceutical, Inc. $19.47 07/25/2024 Food and Beverage Undisputed 01/23/2026 1118975046 CMS
Travere Therapeutics, Inc. $6.04 06/04/2024 Food and Beverage Undisputed 01/23/2026 1149923295 CMS
Travere Therapeutics, Inc. $7.85 06/10/2024 Food and Beverage Undisputed 01/23/2026 1149923302 CMS
Travere Therapeutics, Inc. $13.61 08/14/2024 Food and Beverage Undisputed 01/23/2026 1149923306 CMS
Travere Therapeutics, Inc. $3.71 09/04/2024 Food and Beverage Undisputed 01/23/2026 1149923291 CMS
Travere Therapeutics, Inc. $7.25 09/23/2024 Food and Beverage Undisputed 01/23/2026 1149923298 CMS
Travere Therapeutics, Inc. $3.25 12/03/2024 Food and Beverage Undisputed 01/23/2026 1149923287 CMS
Vifor Pharma, Inc. $17.21 03/27/2024 Food and Beverage Undisputed 01/23/2026 1124037642 CMS
Xeris Pharmaceuticals, Inc. $17.86 07/30/2024 Food and Beverage Undisputed 01/23/2026 1144608487 CMS
Xeris Pharmaceuticals, Inc. $18.32 08/14/2024 Food and Beverage Undisputed 01/23/2026 1144608489 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.